INTRODUCTION {#sec1-1}
============

*A* *spergillus fumigatus* is currently the most important airborne fungal pathogen and the leading cause of invasive aspergillosis (\~85% of cases)\[[@ref1]\]. Despite the introduction of new effective antifungal drugs, the mortality rate of invasive aspergillosis still exceeds 40%\[[@ref2]\]. Furthermore, the emergence of drug resistance adds more complications to the treatment process. Hence, new antifungal agents are urgently needed.

While the classical cell-based screening method has been successfully used in drug discovery process\[[@ref3]\], it is an expensive, time-consuming and labor-intensive approach\[[@ref4]\]. Recent advances in application of computation methods in genome, proteome, and metabolome mining coupled with complete genome sequences of pathogen organisms have opened an alternative path toward identifying new drug targets. For instance, several reports have confirmed the usefulness of comparative genome analysis in identification of pathogen-specific drug and vaccine candidates\[[@ref5]-[@ref7]\].

The genome of *A. fumigatus* contains \~9900 genes, but few antifungal targets have been developed yet\[[@ref8]\]. In the present study, we compared the whole proteome of *A. fumigatus* with *Saccharomyces cerevisiae*, as a non-pathogen fungal organism, to identify *Aspergillus*-specific proteins. Amongst the proteins, those with close homologues to human were removed, and the final targets were selected. One novel target, the aspergillus fumigatus RNA-binding protein (AfuRBP), was selected and found to be a peptidylprolyl isomerase (PPI). For further functional studies, *AfuRbp* knock out and knock down mutant strains were generated. MIC assay with known inhibitors, phenylglyoxal and juglone, and a synthetic derivative of juglone confirmed the higher sensitivity of the mutants to these compounds when compared to the wild-type strain.

MATERIALS AND METHODS {#sec1-2}
=====================

Comparative analysis of *A. fumigatus* and *S. cerevisiae* proteome {#sec2-1}
-------------------------------------------------------------------

The identification of novel drug targets against *A. fumigatus*, as a human pathogen, was based on alignment of its proteome with the proteome of *S. cerevisiae*. The proteomes of these two fungi were extracted from NCBI (<https://www.ncbi.nlm.nih.gov/genome/browse/>). Three different approaches were used to identify and confirm those sequences that are present in *A. fumigatus* but are absent or significantly diverge from *S. cerevisiae*. LAST (<http://last.cbrc.jp>)\[[@ref9]\] has been used as a fast sequence alignment tool to identify unique sequences for *A. fumigatus*. LAST uses variable-length (spaced) seeds realized by a suffix array\[[@ref10]\]. The expected value of 10 (-e84) was chosen to obtain higher sensitivity (-m1000000), and the other settings and parameters were used as default. In the next step, unique sequences from *A. fumigatus* were compared using suffix tree analysis by Mummer (version 3.0) ([http://mummer.sourceforge. net](http://mummer.sourceforge.net))\[[@ref11]\]. Minimum maximal match was seven to restrict output proteins, but other settings were chosen as default. Finally, the proteins that were unique to fungi were identified by BlastP (NCBI Blast v. 2.2.1)\[[@ref12]\]. Modeling was carried out by I-TASSER server (Michigan University, USA)\[[@ref13]-[@ref15]\]. Docking of the compounds was performed by HEX 6.3 software when required.

Strains, plasmids, and culture conditions {#sec2-2}
-----------------------------------------

*A. fumigatus* akuAKU80 and its *pyrG^-^* derivative (akuAKU80 pyrG-) with a highly efficient homologous recombination background were used for isolation of *AfuRbp* gene homologue and gene disruption or gene silencing experiments. *E. coli* Top10 (Invitrogen, USA) cells and pGEM--T Easy cloning system (Promega, USA) were used in all DNA recombinant procedures. Plasmid PGEM-GlaA comprising *Aspergillus niger* glucoamylase A (glaA) promoter and glaA termination signal was used for preparation of RNAi plasmid. All molecular methods including PCR and RT-PCR were performed based on established protocols\[[@ref16]\]. In RT-PCR settings, 1 µg of total RNA was used in cDNA synthesis reactions and the *A. fumigatus* actin gene (AFUA_6G04740) was used as a loading control. Fungal strains were grown and kept on SAB agar or SAB agar medium supplemented with uridine and uracil. Modified Vogel's medium\[[@ref17]\] was used in isolation of fungal transformants.

Construction of *AfuRbp* deletion/silencing cassettes and strains {#sec2-3}
-----------------------------------------------------------------

For construction of the *AfuRbp* deletion cassette, a sequential cloning strategy was applied as described before\[[@ref18]\]. Briefly, 1.5 kb of 5' and 1.2 kb of 3' flanking regions of the gene were amplified separately, using RBP_KO1/RBP_KO2 (containing *Sph*I/*Nco*I restriction sites) and RBP_KO3/RBP_KO4 (containing *Eco*RI/*Sal*I restriction sites) primer sets, respectively ([Table 1](#T1){ref-type="table"}). These fragments were cloned next together in pGEM-Teasy vector. At the final step, the *A. fumigatus* *pyrG* gene, as a selection marker, with its own promoter and terminator containing *Eco*RI site at both ends was cloned into *Eco*RI site, between the 5'and 3' flanking regions, resulted in pRBP-KO ([Fig. 1A](#F1){ref-type="fig"}).

###### 

Primers used in this study

  Name          Sequence (5\`-3\`)                          Enzymes
  ------------- ------------------------------------------- -----------------
  RBP_KO1       GGGCCC[*GCATGC*]{.ul}TCTCTTCAGCTCTGTGGTTG   *Sph*I
  RBP_KO2       [*CCATGG*]{.ul}CATACACTCGAGCACGGTCG         *Nco*I
  RBP_KO3       [*GAATTC*]{.ul}AATGCGTGATGTTG               *Eco*RI
  RBP_KO4       [*GTCGAC*]{.ul}GTCAGTTGACAGAGCGAG           *Sal*I
  RBP_SENSE_F   G[*AGATCT*]{.ul}CCATCCCATTGTTGTT            *Bgl*II
  RBP_SENSE_R   T[*GATATC*]{.ul}TGCTCCTGCTGTCGGCGT          *Eco*RV
  RBP-F         AAGTTCATGGAAAAGTGGGC                        *\-\-\-\-\-\--*
  RBP-R         AGTCAGTTGACAGAGCGAGG                        *\-\-\-\-\-\--*
  RBP_rt1       CCCCTGAGGTTGAGGAGCGG                        *\-\-\-\-\-\--*
  RBP_rt2       CGAGGTTCTGCACTTTGGCG                        *\-\-\-\-\-\--*
  GFP_F         [*GATATC*]{.ul}GTCCAGGAGCGCAC               *Eco*RV
  GFP_R         [*AAGCTT*]{.ul}CTCGATGCGGTT                 *Hind*III
  ACT-F         ATGTCACTGTGCAGATTGTC                        *\-\-\-\-\-\--*
  ACT-R         CGTAGAGGGAGAGAACGGCC                        *\-\-\-\-\-\--*

![Gene constructs and molecular validations. Schematic representation of constructed plasmids used in gene deletion (pRBP-KO) (A) and RNAi (pRBP_RNAi) (B) experiments. (C) PCR analysis of wild-type (lane 1) and deletant strain (lane 2) genome using primers RBP-F1 and RBP-R1. The amplification of a 4.6-kb product confirmed the replacement of native *AfuRbp* with the disrupted fragment. (D) RT-PCR analysis of RNAi transformant grown in maltodextrin or glucose medium for 24 h. Lane 1, actin fragment amplified from the genome (560 bp); lane 2, actin fragment amplified from cDNA originated from glucose; lane 3, maltodextrin cultures (485 bp); lane 4, AfuRbp expression level in RNAi transformant grown in glucose medium; lane 5, maltodextrin medium. *AfuRBP*-specific RT-PCR primers, RBP_rt1/rt2, amplified a 300-bp product. M, DNA size marker](IBJ-21-84-g001){#F1}

To generate the *AfuRbp* silencing cassette, an inducible RNAi transcriptional unit was designed based on a previously described protocol\[[@ref19], [@ref20]\]. This unit was driven by the glaA promoter and comprises an approximately 500 bp Rbp fragment (sense, nucleotides 342-841), followed by a 100-bp buffer EGFp fragment and the same \~500 bp Rbp fragment in the opposite direction (antisense). Sense and antisense fragments were amplified by PCR using primers RBP_SENSE_F and RBP_SENSE_R carrying appropriate restriction sites ([Table 1](#T1){ref-type="table"}) and cloned into PGEM-GlaA vector. A 100-bp EGFP fragment was then amplified by PCR using specific primers ([Table 1](#T1){ref-type="table"}) and cloned between the latter fragments to generate final silencing cassette (pRBP_RNAi) ([Fig. 1B](#F1){ref-type="fig"}).

The prepared constructs were used to transform *A*. *fumigatus* KU80ΔpyrG strain as described before\[[@ref21]\]. Positive transformants were selected on Vogel's minimal medium lacking uracil/uridine supplements. To find the knock out strains, transformants were screened by PCR using primers RBP-F and RBP-R ([Table 1](#T1){ref-type="table"}). As the silencing construct, pRBP_RNAi did not contain any fungal selection marker, the pRG3- AMA1 vector containing the pyrG selection marker was used as the second plasmid in co-transformation reaction. RNAi transformants were also selected based on PCR using *gfp*- and *AfuRbp-*specific primers.

Susceptibility testing {#sec2-4}
----------------------

MICs were determined based on CLSI Broth Microdilution Method (M38-A2 Document) with some modifications. Briefly, fungal spores (10^4^/well) were inoculated in 96-well microtiter plates containing RPMI 1640 medium enriched by 2% glucose (or maltodextrin), and the susceptibility was assessed at a final compound concentration range of 0-200 µg/ml after 48 h. All MIC assays were performed in triplicates. Based on orthology and EC number (EC: 5.2.1.8) of AFUA_2G07650 (AfuRBP), two organic inhibitors of the PPI activity, i.e. phenylglyoxal and juglone (5-hydroxy-1,4-naphthoquinone), were found by searching BRENDA enzyme database ([www.brenda-enzymes.info](http//www.brenda-enzymes.info)) and tested ([Fig. 2](#F2){ref-type="fig"}). A synthetic derivative of juglone, 5-O-Acetoxy-1,4-naphthoquinone (juglone acetate, JA), was also prepared using a previously published method\[[@ref13]\] and assessed in MIC tests. This derivative was made to make the compound more lipophilic.

![List of enzymes (EC number) targeted by juglone or phenylglyoxal. The peptidylprolyl isomerase is the only overlap target for both juglone and phenylglyoxal as inhibitors.](IBJ-21-84-g002){#F2}

Docking and homology modeling {#sec2-5}
-----------------------------

For bioinformatics assessment of the chemical inhibitors used in MIC assays, the 3D structure of AfuRBP was predicted by I-TASSER. The predicted binding sites were subsequently used for docking of the inhibitors. HEX 6.3, ArgusLab (v.4.0.1, <http://www.arguslab.com/arguslab.com/Publications.html>), and WebLab Viewer Lite (v. 4.2) were used for docking of the inhibitors and manipulation of the protein.

RESULTS {#sec1-3}
=======

Identification of target proteins based on *in silico* comparative analyses {#sec2-6}
---------------------------------------------------------------------------

Based on the LAST alignment of the *A. fumigatus* proteome (9630 proteins) against *S. cerevisiae*, 474 unique proteins were recognized in *A. fumigatus* as the homologous of these proteins were not present in *S. cerevisiae*. All of the 474 proteins were further examined in KEGG, NCBI, EXPASY, and EBI databases. It was found that the functions of 161 proteins have already been explained, and their accession numbers are available. The remaining 313 proteins were found to be hypothetical (data not shown). Finally, 50 out of 161 protein candidates were chosen as they were fungal-specific but not present in *S. cerevisiae* ([Table 2](#T2){ref-type="table"}). The RBP, as a potential drug target, was selected for further evaluation. This protein is encoded by an 1158-bp gene located on chromosome 2 and has been annotated as a PPI.

###### 

List of selected proteins specific to fungi other than *S. cerevisiae*

  No.   Accession no.   Description                                                                                 Taxonomy                                           Orthology
  ----- --------------- ------------------------------------------------------------------------------------------- -------------------------------------------------- -----------------------------------------------------
  1     AFUA_8G06570    Acetylxylan esterase ((EC:3.-.-.-)                                                          Dikarya                                            Acetylxylan esterase \[EC:3.1.1.72\]
  2     AFUA_4G00860    Cell surface protein                                                                        Pezizomycotina                                     
  3     AFUA_1G13450    Cell wall proline-rich protein                                                              Pezizomycotina                                     
  4     AFUA_6G14090    CFEM domain protein                                                                         Leotiomyceta                                       
  5     AFUA_4G12450    Conserved lysine-rich protein                                                               Pezizomycotina                                     
  6     AFUA_4G13230    Developmental regulatory protein WetA                                                       Saccharomyceta^[†](#t2f1){ref-type="table-fn"}^    
  7     AFUA_8G00250    Dimethylallyl tryptophan synthase (EC:2.5.1.-)                                              Leotiomyceta                                       N-dimethylallyltransferase \[EC:2.5.1.-\]
  8     AFUA_7G01280    DNA damage response protein RcaA                                                            Metazoa                                            
  9     AFUA_7G06740    Endoglucanase (EC:3.2.1.4)                                                                  Metazoa                                            Endoglucanase \[EC:3.2.1.4\]
  10    AFUA_6G11980    Exo-beta-1,3-glucanase (EC:3.2.1.58)                                                        Dikarya                                            glucan 1,3-beta-glucosidase \[EC:3.2.1.58\]
  11    AFUA_6G14070    Extracellular glycine/serine-rich protein                                                   *Neosartorya fischeri* & *Aspergillus fumigatus*   
  12    AFUA_5G01620    Extracellular proline-rich protein                                                          Eurotiomycetidae                                   
  13    AFUA_8G07090    Extracellular proline-serine-rich protein                                                   Dikarya                                            
  14    AFUA_7G02060    Extracellular serine-rich protein                                                           Leotiomyceta                                       
  15    AFUA_7G02460    Extracellular serine-rich protein                                                           Trichocomaceae                                     
  16    AFUA_6G00670    Extracellular serine-rich protein                                                           Dikarya                                            
  17    AFUA_7G00320    Extracelular proline-glycine-rich protein                                                   Leotiomyceta                                       
  18    AFUA_7G05650    Glutamine-serine-rich protein MS8                                                           Leotiomyceta                                       
  19    AFUA_7G04870    Glutamine-serine-proline-rich protein                                                       Saccharomyceta^[†](#t2f1){ref-type="table-fn"}^    
  20    AFUA_6G10580    GPI anchored CFEM domain protein                                                            Dikarya                                            
  21    AFUA_8G04860    GPI anchored glycoprotein                                                                   Leotiomyceta                                       
  22    AFUA_6G14010    GPI anchored protein                                                                        Leotiomyceta                                       
  23    AFUA_4G09600    GPI anchored protein                                                                        Metazoa                                            
  24    AFUA_7G00970    GPI anchored serine-threonine-rich protein                                                  Leotiomyceta                                       
  25    AFUA_4G08295    Histone h1.3.                                                                               Leotiomyceta                                       
  26    AFUA_8G07060    Hydrophobin                                                                                 Leotiomyceta                                       
  27    AFUA_8G01790    Integral membrane protein                                                                   Leotiomyceta                                       
  28    AFUA_6G04280    Integral membrane protein                                                                   Leotiomyceta                                       
  29    AFUA_5G00620    Integral membrane protein                                                                   Leotiomyceta                                       
  30    AFUA_1G11380    Integral membrane protein                                                                   Leotiomyceta                                       
  31    AFUA_8G01190    Isoamyl alcohol oxidase                                                                     Leotiomyceta                                       
  32    AFUA_5G03980    LysM domain protein                                                                         Leotiomyceta                                       
  33    AFUA_6G03050    Oleate delta-12 desaturase (EC:1.14.99.-)                                                   Dikarya                                            omega-6 fatty acid desaturase (delta-12 desaturase)
  34    AFUA_8G02230    Serine-leucine-rich repeat protein                                                          *Aspergillus fumigatus*                            
  35    AFUA_1G13830    Threonine-rich protein                                                                      Eurotiomycetidae                                   
  36    AFUA_1G02270    ARS-binding protein Abp2                                                                    Ascomycota                                         
  37    AFUA_5G05990    AT DNA-binding protein                                                                      Leotiomyceta                                       
  38    AFUA_3G08110    Cell wall protein                                                                           Ascomycota                                         
  39    AFUA_5G09580    Conidial hydrophobin Hyp1/RodA                                                              Leotiomyceta                                       
  40    AFUA_5G09010    Conserved glutamic acid-rich protein                                                        Pezizomycotina                                     
  41    AFUA_3G12790    Conserved glutamic acid-rich protein                                                        Eurotiomycetidae                                   
  42    AFUA_1G05290    Endo-1,3(4)-beta-glucanase (EC:3.2.1.6); K01180 endo-1,3(4)-beta-glucanase \[EC:3.2.1.6\]   Fungi                                              endo-1,3(4)-beta-glucanase \[EC:3.2.1.6\]
  43    AFUA_3G13110    Extracellular serine-threonine-rich protein                                                 Leotiomyceta                                       
  44    AFUA_5G14210    Glucose repressible protein Grg1                                                            Dikarya                                            
  45    AFUA_1G11220    GPI anchored protein                                                                        Trichocomaceae                                     
  46    AFUA_1G03630    GPI anchored serine-threonine-rich protein (EC:3.1.1.5) lysophospholipase                   Fungi                                              
  47    AFUA_5G13725    Integral membrane protein                                                                   Pezizomycotina                                     
  48    AFUA_3G08670    Integral membrane protein                                                                   Leotiomyceta                                       
  49    AFUA_3G00830    Pfs domain protein                                                                          Leotiomyceta                                       
  50    AFUA_2G07650    RNA-binding protein (EC:5.2.1.8); K01802 Peptidylprolyl isomerase \[EC:5.2.1.8\]            Trichocomaceae                                     peptidylprolyl isomerase \[EC:5.2.1.8\]

Orthology is specified where data exist.

excluding *S. cerevisiae*

Disruption of AfuRbp in *A. fumigatus* {#sec2-7}
--------------------------------------

The *Sph*I/*Sal*I pRBP-KO fragment was used for transformation of *A. fumigatus* (akuAKU80 pyrG-) protoplasts. Through the PCR screening of transformants, a deletion strain was isolated and examined further. In this transformant, RBP-F1 and RBP-R1 primers amplified a fragment of \~4.6 kb (KO) instead of a 3.8-kb wild-type fragment, confirming the replacement of native gene with disrupted one ([Fig. 1C](#F1){ref-type="fig"}). RT-PCR analysis of the deletant revealed that *AfuRbp* does not express in this mutants (data not shown). The growth phenotype of this mutant in various media containing different carbon and nitrogen sources was similar to the parental strain, indicating that *AfuRbp* is not essential in *A. fumigatus*. In PCR screening of RNAi transformants, one positive integrant was selected. This transformant was grown in *glaA*-inducing medium containing 1% maltodextrin, as the sole carbon source. Semi-quantitative RT-PCR analysis using primers RPB-rt1 and RBP-rt2 showed the down-regulation of *AfuRbp* expression in the presence of maltodextrin ([Fig. 1D](#F1){ref-type="fig"}). Phenotypic analysis of this transformant in inducing medium re-confirmed the non-essential role of *AfuRbp* in fungal growth.

Effect of juglone and the synthetic compound on the mutant strains {#sec2-8}
------------------------------------------------------------------

To test whether the deletion or down-regulation of *AfuRbp* has any effect on drug susceptibility of the fungus, MIC levels were determined for phenylglyoxal, juglone, and JA. [Table 3](#T3){ref-type="table"} demonstrates MIC values for these compounds. The results demonstrated a higher sensitivity of all strains to juglone compared to phenylglyoxal and JA. While the phenylglyoxal compound did not appear as a strong antifungal inhibitor, the mutant strains showed more sensitivity to this chemical. MIC assays for RNAi transformant was performed in maltodextrin medium. The higher sensitivity of RNAi transformant in maltodextrin medium compared to the glucose medium indicated that the down-regulation of *AfuRbp* can affect the strain susceptibility to PPI inhibitors.

###### 

*In vitro* activity of compounds against wild-type and *AfuRbp* mutants of *A. fumigatus* by MIC test (µg/ml)

  Inhibitor         Wild strain   KO mutant   RNA~i~ mutant                 
  ----------------- ------------- ----------- --------------- ------ ------ ------
  Juglone           3.12          3.12        1.56            1.56   3.12   1.56
  Phenylglyoxal     200           200         100             100    200    100
  Juglone acetate   6.25          6.25        3.12            3.12   6.25   3.12
  Amphotericin B    1.56          1.56        1.56            1.56   1.56   1.56

Outcome of modeling and docking for AfuRBP as a model {#sec2-9}
-----------------------------------------------------

As we could not find any template protein having a minimum 35% similarity to our target protein, a threading algorithm for RBP protein modeling was used by I-TASSER server. Five models were generated, and according to the I-TASSER validation criteria, model number one had the least calculation errors and fitted best within the X-ray/NMR 3D population criteria ([Fig. 3](#F3){ref-type="fig"}). In this study, five top models proposed by I-TASSER were used as receptors of the docking experiments, and phenylglyoxal, juglone, and JA were used as ligands. Docking outcome showed that the interaction of model number 4 with JA produced a proper energy (-186.3), which indicates the highest absolute value among the docking results. Other docking outcomes that were sorted by energy are shown in [Table 4](#T4){ref-type="table"}.

![The five predicted three-dimensional structures of AfuRBP protein obtained by homology modeling with I-TASSER. Model numbers: 1 (A), 2 (B), 3 (C), 4 (D), 5 (E).](IBJ-21-84-g003){#F3}

###### 

The results of Docking experiments

  Dock name                   Produced energy of interaction (kJ/mol)   Position (supercoil)                                                  Position (alphaa helix)   Position (beta sheet)
  --------------------------- ----------------------------------------- --------------------------------------------------------------------- ------------------------- -----------------------
  Model4 with JA              -186.3                                    8-9-10-11-243-244-275-317                                             245-246-247               276-277
  Model3 with JA              -184.7                                    347-348-349-350-366-367-368-369-370-371                               None                      317-318-319-320-321
  Model1 with JA              -174.5                                    220-221-222-223-224-225-226-227-228-229-230-231-232-233-234-235-236   237-238-239-240           None
  Model5 with JA              -174.4                                    109-110-111-112-113-114-115-131-132-133-134-135-136-181-182-183       None                      None
  Model3 with juglone         -166.4                                    324-325-350-356-357-358-363-364                                       None                      None
  Model2 with JA              -162.5                                    80-81-82-83-84-85-126-127-128                                         None                      79-86-87
  Model4 with juglone         -161.7                                    74-75-156-157-158-351-352                                             None                      None
  Model3 with phenylglyoxal   -153.12                                   354-355-356                                                           None                      None
  Model1 with juglone         -152                                      26-27-28-29-30-31-213-214-215-216                                     None                      None
  Model4 with phenylglyoxal   -146.5                                    383-384-385                                                           None                      None
  Model1 with phenylglyoxal   -146.1                                    243-244-245-246-247                                                   279-280                   None
  Model2 with phenylglyoxal   -143.5                                    143-144-145-157-158                                                   229-230-231               219-220-221
  Model5 with phenylglyoxal   -117.3                                    167-168-169-170-171-172-173-174-175                                   None                      None
  Model5 with juglone         -31.9                                     82-83-84-85-86-87                                                     None                      126-127
  Model2 with juglone         0                                         None                                                                  None                      None

The synthetic compound (JA), juglone and phenylglyoxal, were used as ligands and the five predicted models (1, 2, 3, 4, and 5) were used as receptors. Position of docked ligand and binding sites for docking results with their energy values are indicated in the Table. Docking was performed by HEX 6.3 software.

DISCUSSION {#sec1-4}
==========

Because of the common eukaryotic origin of fungi and mammals, the development of new antifungal drugs has been challenging. This may be the reason for the introduction of only five classes of antifungal agents, including fluorinated pyrimidine analogs, polyenes, allylamines, azoles, and echinocandins\[[@ref22]\]. Here, we have tried to find some novel drug targets against *A. fumigatus* using bioinformatics. Our alignment has demonstrated a group of proteins/genes ([Table 2](#T2){ref-type="table"}) that are fungal-specific and may be essential to *A. fumigatus*. Our highlights differ from other studies such as Abadio and colleagues\[[@ref23]\] in comparative alignment as we searched for those novel targets that only exist in *A. fumigatus*. In this study, we found a RNA-binding protein (AfuRBP) that has been annotated as a member of PPI enzyme family. The PPI family contains three members, including cyclophilins, FKBPs, and Parvulin\[[@ref24]\]. Cyclophilins are described by an eight-standard β-barrel that forms a hydrophobic pocket. FKBPs, instead, contain an amphipatic, five-stranded β-sheet that enfolds around a single, short α-helix\[[@ref25], [@ref26]\]. Members of Parvulin family contain a PPI domain consisting of a half β-barrel and its four antiparallel strands surrounded by four α-helices. The results of I-TASSER modeling and docking demonstrated that the AfuRBP is structurally closer to Parvulin family members of PPI enzyme family. To elucidate the function of this protein, *AfuRbp*-deficient strains were generated using gene deletion and RNAi strategies. Normal phenotype of these strains indicated a non-essential role for this protein in growth physiology of *Aspergillus fumigatus*. Some studies have demonstrated that the inactivation of a drug target gene can result in increased sensitivity of the organism to the drug or other compounds that inhibit the same pathway\[[@ref27], [@ref28]\]. In this sense, the sensitivity of *AfuRbp*-disrupted strains to PPI inhibitors was assessed.

Juglone showed the highest inhibitory effect on the mutants and wild strain. In addition, we used JA as an inhibitor to investigate the change in the structure of juglone through modification of its hydroxyl group in order to increase the hydrophobicity. The decision to produce JA was partly due to the predicted activity of this derivative through the docking scores, which had a higher absolute energy of interaction than juglone. Overall, MIC test of JA demonstrated different results for the mutant and wild strains. Although docking showed a high potential for JA, the MIC test indicated slight decrease in activity, which might be due to lipophilic binding of JA to other cell components.

Considering the specific inhibitory effect of juglone on Parvulin\[[@ref29]\] and the higher sensitivity of *AfuRbp* deficient mutants to this chemical compared to the parental strain, it can be concluded that juglone may act as a specific inhibitor of the AfuRBP. More detailed studies on recombinant AfuRBP may verify this claim.

In conclusion, in this study, the bioinformatics and biological assessments of AfuRBP were carried out, and the presented data can be considered as a start for pin pointing a target towards developing a new drug against *A. fumigatus*.
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